Potential savings from increased use of generic drugs in the elderly: what the experience of Medicaid and other insurance programs means for a Medicare drug benefit.

@article{Fischer2004PotentialSF,
  title={Potential savings from increased use of generic drugs in the elderly: what the experience of Medicaid and other insurance programs means for a Medicare drug benefit.},
  author={Michael A. Fischer and Jerry Avorn},
  journal={Pharmacoepidemiology and drug safety},
  year={2004},
  volume={13 4},
  pages={207-14}
}
BACKGROUND Generic medications provide the same clinical effect at lower cost than brand name drugs but little is known about the extent to which such savings are achieved in drug benefit programs serving the elderly. METHODS Using patient-level claims data for participants aged 65 or more in one state Medicaid program and in a non-Medicaid drug insurance program for the elderly, we compared the expenditures in each program for brand name prescriptions with the amount that would have been… CONTINUE READING